FDA Approved: RELISTOR — Original Application (Salix Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Relistor (methylnaltrexone bromide) as an original NDA submission by Salix Pharmaceuticals, marking its regulatory clearance for opioid-induced con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• RELISTOR (methylnaltrexone)

Snippet

ORIG AP for RELISTOR (METHYLNALTREXONE BROMIDE)